Skip to content

Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women

Study on the Correlation Between Changes in Steroid Hormone Levels and Stress Urinary Incontinence in Women

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06109623
Enrollment
1226
Registered
2023-10-31
Start date
2023-11-15
Completion date
2023-12-01
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence,Stress

Keywords

Stress Urinary Incontinence, Steroid Hormone, Case-Control Study

Brief summary

The goal of this observational study is to learn about the relationship between stress urinary incontinence and endogenous steroids in women, especially its occurrence and severity with androgens and estrogens. The main questions it aims to answer are: * Association between stress urinary incontinence and endogenous steroids in women * Risk factors associated with stress urinary incontinence in women Participants will be asked to provide basic clinical information as well as results of measurements of serum steroid hormone levels. Researchers will compare Stress urinary incontinence group and control group to see if the changes of sex hormone levels were statistically significant.

Detailed description

By comparing the differences of six hormones between female patients with stress urinary incontinence (SUI) and non-SUI patients (patients without pelvic floor muscle dysfunction and lower urinary tract dysfunction) aged ≥20 years, especially the changes of androgen and estrogen levels, the correlation between the changes of hormone levels and stress urinary incontinence was obtained. Multivariate logistic regression analysis was used to analyze the relationship between hormones and urinary incontinence, and further correlation analysis was performed for statistically significant hormones. Estrogen and androgen were divided into four groups: normal estrogen/normal androgen group, decreased estrogen/normal androgen group, normal estrogen/decreased androgen group, decreased estrogen/decreased androgen group. Stratified analysis was performed to analyze whether there was an interaction between the two hormones and exclude confounding effects. Finally, the data were further analyzed by sensitivity analysis of baseline characteristics, and the known risk factors were verified in this trial, including age, parity, menopausal status, genetic factors, obesity, and on this basis, the correlation between pelvic surgery history, diabetes, hypertension, smoking and stress urinary incontinence was explored.

Interventions

OTHERobservation

To observe the changes and differences of steroid hormones between stress urinary incontinence group and control group.

OTHERsex hormone

Six indicators of steroid hormones (estrogen, testosterone, follicle stimulating hormone, luteinizing hormone, pituitary prolactin, progesterone)

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Experimental Group 1. women aged ≥20 years 2. Stress urinary incontinence diagnosed in our hospital; 3. Six hormone tests were performed in our hospital; Control group (1) women aged ≥20 years; (2) diseases other than stress urinary incontinence diagnosed by our hospital; (2) Six hormone tests were performed in our hospital;

Exclusion criteria

1. Pelvic organ prolapse, overactive bladder, urge urinary incontinence, overflow urinary incontinence, mixed urinary incontinence; 2. patients who received hormone replacement therapy within 6 months; 3. estrogen-dependent diseases, such as endometriosis, uterine leiomyoma, ovarian tumors; 4. the presence of gynecological malignant tumors or other diseases affecting hormone secretion; 5. the presence of nervous system diseases.

Design outcomes

Primary

MeasureTime frameDescription
Baseline characteristicsbaseline, pre-procedureThe results of this study were described by statistical methods. Descriptive statistical analysis was performed on the baseline characteristics of patients in the SUI group and the control group. Categorical variables were described by frequency (%), and Pearson chi-square test or Fisher Exact test was used. Continuous variables describe their mean (SD) or median data (interquartile range) according to their normality, and comparisons between groups were performed using the independent t-test (normal) or Mann Whitney test (non-normal).
Association analysis between stress urinary incontinence and androgen levelsimmediately after the procedureThe association between stress urinary incontinence and the lowest quartile of serum testosterone was examined by a weighted, multivariate logistic regression model. Odds ratios and 95% confidence intervals were calculated for each outcome of interest. All models were adjusted for age, BMI, parity, menopausal status, history of pelvic surgery, hypertension, and diabetes. Two-sided p values of 0.05 or less were considered to indicate statistical significance.

Secondary

MeasureTime frameDescription
Sensitivity analysis or stratified analysisthrough study completion, an average of 6 monthThe association between hormone levels and stress urinary incontinence is affected by many uncertain factors, such as population characteristics and disease history. In order to avoid bias of results caused by uncertain factors, sensitivity analysis or stratified analysis of these factors is required. This project planned to perform sensitivity or stratified analyses by grouping the subjects into multiple subgroups (grouped by age, history of childbirth, history of hypertension, history of diabetes, history of pelvic surgery, etc.).

Contacts

Primary ContactZhang Jing-Yan
windsor0525@163.com+8619117170882

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026